Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
9th Jun 20173:00 pmRNSHolding(s) in Company
5th Jun 20173:30 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:03 amRNSScrip Reference Share Price
31st May 20173:00 pmRNSTotal Voting Rights
25th May 20179:20 amRNSHolding(s) in Company
22nd May 20173:52 pmRNSDirector/PDMR Shareholding
17th May 20177:00 amRNSHalf Year Results
8th May 20174:15 pmRNSDirector/PDMR Shareholding
2nd May 201711:00 amRNSTotal Voting Rights
10th Apr 20172:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:30 pmRNSBlock listing Interim Review
31st Mar 201711:30 amRNSTotal Voting Rights
31st Mar 201711:00 amRNSNotice of Half Year Results
13th Mar 20173:30 pmRNSDirector/PDMR Shareholding
2nd Mar 201712:51 pmRNSDirector/PDMR Shareholding
28th Feb 20173:30 pmRNSTotal Voting Rights
13th Feb 20173:30 pmRNSDirector/PDMR Shareholding
9th Feb 20172:30 pmRNSDirector/PDMR Shareholding
8th Feb 20175:06 pmRNSHolding(s) in Company
7th Feb 201712:15 pmRNSDirector/PDMR Shareholding
7th Feb 201712:03 pmRNSTotal Voting Rights
6th Feb 20174:30 pmRNSHolding(s) in Company
31st Jan 20172:15 pmRNSTotal Voting Rights
25th Jan 20172:45 pmRNSAdditional Listing
25th Jan 201710:45 amRNSAdditional Listing
25th Jan 20179:45 amRNSResult of AGM
17th Jan 20173:00 pmRNSHolding(s) in Company
17th Jan 20171:30 pmRNSDirector/PDMR Shareholding
13th Jan 20177:00 amRNSFirst Quarter Trading Update
11th Jan 201710:30 amRNSNotice of first quarter trading update
3rd Jan 201711:30 amRNSTotal Voting Rights
20th Dec 201611:00 amRNSDirector/PDMR Shareholding
15th Dec 201612:00 pmRNSAnnual Report 2016
5th Dec 201612:45 pmRNSHolding(s) in Company
1st Dec 201610:00 amRNSTotal Voting Rights
25th Nov 201611:54 amRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSFULL YEAR RESULTS
21st Nov 201612:00 pmRNSDirector/PDMR Shareholding
15th Nov 20164:17 pmRNSHolding(s) in Company
1st Nov 201612:30 pmRNSTotal Voting Rights
31st Oct 20162:30 pmRNSNotice of Final Results
24th Oct 20163:30 pmRNSDirector/PDMR Shareholding
30th Sep 20162:45 pmRNSBlock listing Interim Review
30th Sep 201611:55 amRNSTotal Voting Rights
26th Sep 20163:00 pmRNSDirector/PDMR Shareholding
23rd Sep 201612:55 pmRNSHolding(s) in Company
22nd Sep 20167:03 amRNSBoard Appointment
22nd Sep 20167:00 amRNSPre-Close Trading Update
14th Sep 201611:30 amRNSAdditional Listing
14th Sep 201610:30 amRNSNotice of Pre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.